• Home
  • about
  • contact
  • twitter
  • archive
  • RSS

Stem Cell Assays

HSC isolation

Identification and isolation of hematopoietic stem cell subsets in human cord blood

by Alexey Bersenev on March 31, 2010 · 1 comment

in cord blood,hematopoietic,protocols

FACS analysis of mouse hematopoietic stem cell subsets – gating strategy

by Alexey Bersenev on February 4, 2010 · 1 comment

in cytometry,hematopoietic

What is lineage-negative cells?

by Alexey Bersenev on November 24, 2009 · 0 comments

in hematopoietic

Next Entries →

  • search

  • follow updates:

    • subscribe via RSS
    • Enter your email address:

  • advertisement

  • our partners:



  • categories

    • adipose (6)
    • cancer (33)
    • cell culture (24)
    • cell product (46)
    • cell separation (8)
    • clinical lab (19)
    • consensus (11)
    • cord blood (16)
    • cytometry (22)
    • direct reprogramming (12)
    • educational (21)
    • embryonic/iPS (65)
    • events (7)
    • gadgets (8)
    • gene transfer (6)
    • hematopoietic (70)
    • interviews (10)
    • lectures (36)
    • mesenchymal (34)
    • methods (30)
    • neural (14)
    • notes (38)
    • open science (24)
    • other adult stem cells (13)
    • protocols (53)
    • RegenMed digest (28)
    • reviews (40)
    • tissue engineering (11)
    • web tools (10)
  • series:

    Experimental bone marrow transplantation 101

    Methods and Protocols Digest

    Mesenchymal Stem Cells – definition and assays

    True Blood - manufacturing blood from stem cells

    RegenMed Digest - industry updates

  • featured posts:

    The definition of stem cell therapy

    10 companies to watch in 2012

    Series of retractions from Amy Wagers’ stem cell lab

    Genomic stability of clinical-grade mesenchymal stromal cells – a proposal for international initiative

    Stem Cell Assays in 2011

  • polls:

    The next generation of potency assays for hematopoietic graft

    What is the correct name for “mesenchymal stem cells”?

    What is the most promising method for targeting cancer stem cells?

    True blood: What approach is more promising for blood manufacturing?

  • recent comments

    • Michael An on Clinical cell processing news – part 1
    • Alexey Bersenev on Till & McCulloch Meetings 2012 – Reflections on Caplan’s view of mesenchymal stem cells
    • Alexey Bersenev on Till & McCulloch Meetings 2012 – Reflections on Caplan’s view of mesenchymal stem cells
    • Owen Bain on Till & McCulloch Meetings 2012 – Reflections on Caplan’s view of mesenchymal stem cells
    • James Eliason on Till & McCulloch Meetings 2012 – Reflections on Caplan’s view of mesenchymal stem cells
  • blogs we recommend:

    Hematopoiesis
    Knoepfler Lab Stem Cell Blog
    Cell Therapy Blog
    Stem Cell Treatment Monitor
    Stem Cell Network Blog
    The Cell Culture Dish

  • popular tags:

    assay BMT model business cancer cancer stem cell CD34 cell culture cell processing cell product cell separation cell therapy clinical-grade clinical trial collaboration conference cord blood direct transdifferentiation embryonic stem cell flow cytometry guidelines HSC HSC isolation iPS jove lecture manufacturing marker market method MSC MSC isolation neural stem cell open science pluripotency progenitor protocol regenerative medicine RegenMed reprogramming review risk safety tissue engineering video xeno
  • cell therapy trials tracking:

  • databases:

    Cell Image Library Reference

    Stem Cell Lineage Database

    Characterization Tool

    European Human Embryonic Stem Cell Registry

    PluriTest

    StemBase

    StemDB

  • license:

    Creative Commons License
    This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License.
  • Ads

Get smart with the Thesis WordPress Theme from DIYthemes.

WordPress Admin